Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

Celularity Inc

CIK 1752828 CELU·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing Filing comparison

Celularity Inc told the SEC it could not file its quarterly report on time

Does not expect a significant change in results.

(“Celularity”) will be unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2026 (the “June 2026 Form 10-Q”) with the Securities and Exchange Commission (“SEC”) within the prescribed time period. Constraints in Celularity’s liquidity position and financial accounting staffing levels have caused delays in the financial close and reporting process and the preparation of the consolidated financial statements. Celularity is working diligently and plans to file the June 2026 Form 10-Q as soon as practicable.
Evidence
Anticipates significant change
False
Other periodic reports filed
True
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
(“Celularity”) will be unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2026 (the “June 2026 Form 10-Q”) with the Securities and Exchange Commission (“SEC”) within the prescribed time period. Constraints in Celularity’s liquidity position and financial accounting staffing levels have caused delays in the financial close and reporting process and the preparation of the consolidated financial statements. Celularity is working diligently and plans to file the June 2026 Form 10-Q as soon as practicable.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.